Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines - PubMed (original) (raw)
Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines
D L Gibbons et al. Eur J Immunol. 1994 Aug.
Abstract
A critical event in B cell immortalization by Epstein-Barr virus (EBV) is the establishment of an autocrine loop where cells produce a growth factor which supports their own proliferation. We investigated the potential of lymphoblastoid cell lines (LCL) and Burkitt lymphoma (BL) cell lines to produce and respond to the cytotoxins, tumor necrosis factor-alpha (TNF-alpha) and lymphotoxin (LT). Transformation in vitro of peripheral blood B cells by EBV from seven different donors resulted in spontaneous production of both LT (11,542 pg/ml +/- 7546, mean +/- SD) and, to a lesser extent, TNF-alpha (197 pg/ml +/- 174). Similarly BL cell lines derived from in vivo transformation which developed a 'LCL-like' phenotype in vitro (group III) produced more LT (1990 pg/ml +/- 1740) than the 'group I' BL cell lines (< 40 pg/ml LT) which had maintained the original BL biopsy cell phenotype in vitro. Transformation of peripheral blood B cells to generate LCL also resulted in an increase in surface p75 (p < 0.02) and to a lesser extent p55 (not significant, ns) TNF receptor (TNF-R) expression. Similar increases in surface TNF-R (p75 p < 0.02, p55 ns) were observed on the 'group III' BL cell lines compared with the 'group I' BL cell lines. Proliferation of an LCL and a 'group III' BL cell line in vitro was via an autocrine loop since inhibition of LT reduced proliferation. This proliferation could also be blocked in the presence of the antagonistic anti-p55 TNF-R antibody, H398, but not the antagonistic antibody anti-p75 TNF-R antibody UTR-1. Furthermore, proliferation could be induced with the p55 agonistic antibody, HTR-9. In contrast to these observations with p55 TNF-R antibodies, two out of six of the 'group III' BL lines (Jijoye and Oba) only expressed the p75 TNF-R and proliferation of these cells could only be blocked by the antagonistic anti-p75 TNF-R antibody UTR-1. These data suggest that LT is an autocrine growth factor for lymphoblastoid cells, and BL cell lines which display an LCL phenotype. Furthermore, although both TNF-R are increased on the surface of these cells, this autocrine growth signal is mediated principally through binding to the p55 TNF-R.
Similar articles
- Protein kinase C regulates secretion of lymphotoxin (LT/TNF beta) and TNF alpha by human EBV-transformed B cells.
Jochems GJ, Klein MR, Zeijlemaker WP, van Lier RA. Jochems GJ, et al. Hum Antibodies Hybridomas. 1992 Oct;3(4):162-7. Hum Antibodies Hybridomas. 1992. PMID: 1335785 - Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K, Ehlin-Henriksson B, Bartkova J, Bartek J, Scuderi R, Szekely L, Wiman KG, Klein G. Pokrovskaja K, et al. Cell Growth Differ. 1996 Dec;7(12):1723-32. Cell Growth Differ. 1996. PMID: 8959341 - Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
Warzocha K, Bienvenu J, Coiffier B, Salles G. Warzocha K, et al. Eur Cytokine Netw. 1995 Mar-Apr;6(2):83-96. Eur Cytokine Netw. 1995. PMID: 7578992 Review. - Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
Tatsumi E. Tatsumi E. Hum Cell. 1992 Mar;5(1):79-86. Hum Cell. 1992. PMID: 1329932 Review.
Cited by
- Antiproliferative and proapoptotic effects of a pyrrole containing arylthioindole in human Jurkat leukemia cell line and multidrug-resistant Jurkat/A4 cells.
Philchenkov AA, Zavelevich MP, Tryndyak VP, Kuiava LM, Blokhin DY, Miura K, Silvestri R, Pogribny IP. Philchenkov AA, et al. Cancer Biol Ther. 2015;16(12):1820-9. doi: 10.1080/15384047.2015.1078026. Cancer Biol Ther. 2015. PMID: 26785947 Free PMC article. - Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.
Lauenborg B, Christensen L, Ralfkiaer U, Kopp KL, Jønson L, Dabelsteen S, Bonefeld CM, Geisler C, Gjerdrum LM, Zhang Q, Wasik MA, Ralfkiaer E, Ødum N, Woetmann A. Lauenborg B, et al. Oncotarget. 2015 Jun 20;6(17):15235-49. doi: 10.18632/oncotarget.3837. Oncotarget. 2015. PMID: 25915535 Free PMC article. - The role of VEGF in normal and neoplastic hematopoiesis.
Gerber HP, Ferrara N. Gerber HP, et al. J Mol Med (Berl). 2003 Jan;81(1):20-31. doi: 10.1007/s00109-002-0397-4. Epub 2002 Dec 14. J Mol Med (Berl). 2003. PMID: 12545246 Review. - Molecular virology of Epstein-Barr virus.
Bornkamm GW, Hammerschmidt W. Bornkamm GW, et al. Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):437-59. doi: 10.1098/rstb.2000.0781. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11313004 Free PMC article. Review. - Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.
Spender LC, Cornish GH, Rowland B, Kempkes B, Farrell PJ. Spender LC, et al. J Virol. 2001 Apr;75(8):3537-46. doi: 10.1128/JVI.75.8.3537-3546.2001. J Virol. 2001. PMID: 11264343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous